Capnos aims to redefine cessation in an effort to help a portion of one billion smokers quit. Our goal is to innovate upon behavioral addiction research and advocacy for harm reduction using Capnos-flavored pressurized air inhalers. Capnos features value devices, including the Zero and E-Z, along with premium devices like the Legura and BRE-Z. With direct-to-lung and mouth hit devices, our flavored pressurized air inhalers are designed to satisfy oral fixations and hand-to-mouth behavioral cravings. Capnos aims to be the affordable, accessible solution for anyone, anytime, anywhere. We have a global presence and aim to be the leading brand in solving for behavioral cravings through an educative lens and product accessibility.